Literature DB >> 19762497

Method of glomerular filtration rate estimation affects prediction of mortality risk.

Brad C Astor1, Andrew S Levey, Lesley A Stevens, Frederick Van Lente, Elizabeth Selvin, Josef Coresh.   

Abstract

Decreased kidney function, determined using a serum creatinine-based estimation of GFR, is associated with a higher risk for mortality from cardiovascular disease. Equations incorporating cystatin C improve the estimation of GFR, but whether this improves the prediction of risk for mortality is unknown. We measured cystatin C on 6942 adult participants in the Third National Health and Nutrition Examination Survey Linked Mortality File, including all participants who had high serum creatinine (>1.2 mg/dl for men; >1.0 mg/dl for women) or were older than 60 yr and 25% random sample of participants who were younger than 60 yr. We estimated GFR using equations that included standardized serum creatinine, cystatin C, or both. Participant data were linked to the National Death Index. A total of 1573 (22.7%) deaths (713 deaths from cardiovascular disease) occurred during a median of 8 yr. Lower estimated GFR based on cystatin C was strongly associated with higher risk for overall and cardiovascular mortality across the range of normal to moderately decreased estimated GFR. Creatinine-based estimates of GFR resulted in weaker associations, with the association between estimated GFR and all-cause mortality reversed at higher levels of estimated GFR. An equation using both creatinine and cystatin C (in addition to age, race, and gender) resulted in weaker associations than equations using only cystatin C (with or without age, race, and gender). In conclusion, despite better performance in terms of estimating GFR, equations based on both cystatin C and creatinine do not predict mortality as well as equations based on cystatin C alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762497      PMCID: PMC2754107          DOI: 10.1681/ASN.2008090980

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

2.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente
Journal:  Clin Chem       Date:  2007-03-01       Impact factor: 8.327

3.  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures.

Authors: 
Journal:  Vital Health Stat 1       Date:  1994-07

4.  Cystatin C and the risk of death and cardiovascular events among elderly persons.

Authors:  Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

5.  Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Authors:  Michael G Shlipak; Ronit Katz; Mark J Sarnak; Linda F Fried; Anne B Newman; Catherine Stehman-Breen; Stephen L Seliger; Brian Kestenbaum; Bruce Psaty; Russell P Tracy; David S Siscovick
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

6.  Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.

Authors:  Michael G Shlipak; Christina L Wassel Fyr; Glenn M Chertow; Tamara B Harris; Stephen B Kritchevsky; Frances A Tylavsky; Suzanne Satterfield; Steven R Cummings; Anne B Newman; Linda F Fried
Journal:  J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 10.121

7.  Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Anna Köttgen; Elizabeth Selvin; Lesley A Stevens; Andrew S Levey; Frederick Van Lente; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

9.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

10.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

View more
  49 in total

1.  Chronic kidney disease: Endogenous filtration markers--is it time to move beyond eGFR?

Authors:  Andrew D Rule; Hisham Elsherbiny
Journal:  Nat Rev Nephrol       Date:  2011-11-29       Impact factor: 28.314

2.  Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

Authors:  Brad C Astor; Tariq Shafi; Ron C Hoogeveen; Kunihiro Matsushita; Christie M Ballantyne; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2012-02-04       Impact factor: 8.860

3.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

4.  Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).

Authors:  Michelle M Estrella; Brad C Astor; Anna Köttgen; Elizabeth Selvin; Josef Coresh; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

5.  Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III.

Authors:  Mohammed F Faramawi; James L Caffrey; Jamshid Amanzadeh; Lakpa Diku Sharpa; Raquel Qualls-Hampton
Journal:  Eur J Epidemiol       Date:  2010-12-24       Impact factor: 8.082

6.  Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Salman Waheed; Kunihiro Matsushita; Yingying Sang; Ron Hoogeveen; Christie Ballantyne; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2012-04-25       Impact factor: 8.860

7.  Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.

Authors:  Matthias Dupont; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2012-08-16       Impact factor: 8.790

8.  Renal hyperfiltration as a novel marker of all-cause mortality.

Authors:  Minseon Park; Eunsil Yoon; Youn-Hee Lim; Ho Kim; Jinwook Choi; Hyung-Jin Yoon
Journal:  J Am Soc Nephrol       Date:  2014-10-24       Impact factor: 10.121

9.  Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Authors:  Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2011-09-22       Impact factor: 8.860

10.  Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.

Authors:  Morgan E Grams; Stephen P Juraschek; Elizabeth Selvin; Meredith C Foster; Lesley A Inker; John H Eckfeldt; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-04-22       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.